intuitive surgical investor presentation 2021

Fourth quarter 2021 GAAP income from operations included share-based compensation expense of $120 million, compared with $104 million in the fourth quarter of 2020. At the "Pitching to Investors Programme" you will have an exclusive 10-minute pitching slot on stage for you to showcase your company to our entire audience and the biggest community of investors. Yes, Tycho. Marshall L. Mohr Executive Vice President and Chief Financial Officer. Second-quarter 2021 OUS procedure growth was driven by growth in prostatectomy procedures and earlier-stage growth in kidney cancer procedures, general surgery, gynecology, and thoracic. Yeah. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We continue to see significant utilization variance by region due to pandemic differences. SP procedures grew 133% year over year, with much of that growth coming from the United States. The Company defines non-GAAP EPS as non-GAAP net income attributable to Intuitive Surgical, Inc. divided by non-GAAP diluted shares, which are calculated as GAAP weighted-average outstanding shares plus dilutive potential shares outstanding during the period. This MMR report includes investor recommendations based on a thorough examination of the Thoracic Surgery Market's contemporary competitive scenario. In the U.S., Q2 procedure results were positively impacted by a continuing recovery from COVID-19, including, we believe, a number of procedures that had been previously deferred. And we're building into the broader digital ecosystem for SP. Fourth quarter 2022 GAAP income from operations included share-based compensation expense of $129 million, compared with $120 million in the fourth quarter of 2021. At the time you receive a -- by the time you're at -- that market penetration rates that are significant. As I believe that focusing on patient-centered strategies combined with leveraging data for research can help to improve the diagnosis, treatment, and prevention of diseases.<br><br>Patient-centered: I'm raising the bar on patient . As a result, we expect lower trade-in transactions over time. And Jamie, as to kind of where we are. That's right -- theythink these 10stocks are even better buys. Investor's Business Daily . And I'm actually curious more what's going on with service and software at the hospitalwide kind of department of surgery level. Please note that this conference call will be available for audio replay on our website at intuitive.com on the latest Events section under our Investor Relations page. Consistent with the last quarter's forecast, we expect our noncash stock compensation expense to range between $450 million and $470 million in 2021. Capital placements for the first six months of 2021 were in line with procedure and utilization growth. That will play out over the next several quarters as we accrue patients. Phone: 408-523 . These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K filed on February 10, 2021; and Form 10-Q filed on April 21, 2021. Gary will present the quarter's business and operational highlights. The Company defines non-GAAP income from operations as income from operations, excluding amortization of intangible assets, SBC and long-term incentive plan expenses, litigation charges and recoveries, and a gain on the sale of a business. System placements came in above plan, and system ASP and I&A revenue per procedure tracked slightly above our expectations, together driving revenue of $1.46 billion in Q2. Product and brand names/logos are trademarks or registered trademarks of Intuitive Surgical or their respective owner. I will now turn to our financial outlook for 2021. However, our expense growth rate was modestly lower than our plan, driven by pandemic-related factors. Theyjust revealed what they believe are thetenbest stocksfor investors to buy right now and Intuitive Surgicalwasn't one of them! Listen to Webcast. We also find that our economic offerings with da Vinci X and EUP, we have choices that we ourselves can offer our customers. Intuitive Surgical, Inc. is the global technology leader in robotic-assisted minimally invasive surgery (MIS). The Motley Fool recommends the following options: long January 2022 $580 calls on Intuitive Surgical and short January 2022 $600 calls on Intuitive Surgical. And we're pleased. Looking forward, we see the following capital revenue dynamics. On the why side, it's -- bariatrics has been a little different than other procedure for us. It's physically demanding. You may automatically receive Intuitive Surgical financial information by e-mail. Intuitive Announces Fourth Quarter Earnings, Intuitive Announces Preliminary Fourth Quarter and Full Year 2022 Results, Intuitive becomes largest robotic-assisted surgery provider to be accredited by the Royal College of Surgeons of England, Q4 2022 INTUITIVE Earnings Conference Call, INTUITIVE at J.P. Morgan Healthcare Conference, J.P. Morgan Healthcare Conference 2023 Presentation, Q3 2022 INTUITIVE Earnings Conference Call. The increase compared to prior year reflects costs associated with higher headcount, increased variable compensation, and increased spending in areas impacted by COVID. The study contains 371 patients that underwent an incisional hernia repair procedure across 17 institutions within the United States between May 2016 and September 2019. Submit. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. And then now we have rolled it out to most other markets in the first six months of this year, except for China where there are longer regulatory timelines. 3 min read. I will now summarize our GAAP results. It's a short period, but we believe that there is elasticity, and we've seen elasticity in markets where reimbursements are very low. Gross profit, income from operations, net income attributable to Intuitive Surgical, Inc., and net income per diluted share attributable to Intuitive Surgical, Inc. are reported on a GAAP and non-GAAP* basis. And those two things come together, they also allow hospitals to start to address the backlog that's accumulated. During the quarter, a group from the Shenzhen Hospital Naval Medical University in China, published a meta-analysis in BMC cancer comparing robotic-assisted thoracic surgery versus video-assisted thoracic surgery, or VATs, for lung lobectomy or segmentectomy in patients with nonsmall cell lung cancer. Good afternoon, everybody. In this Backstage Pass video, which aired Sept. 29, Motley Fool contributor Brian Withers shares his thoughts on Intuitive Surgical, highlighting the metrics investors need to watch when the . Preliminary full year 2021 systems revenue increased by 44% to approximately $1.69 billion, compared with $1.18 billion in 2020. It's taking getting the advanced instruments, put them together as a set, getting our workflows and our clinical pathways right, and I think that's been powerful to date. OUS markets grew 51% year over year or 19% on a two-year compound annual growth rate basis. And I have one follow-up. We think we stand up pretty well to those comparisons, and we're ready to help them pursue their aims as the year proceeds. Follow Allison Gatlin on Twitter at @IBD_AGatlin . China growth in the second quarter continued to be far higher than our other regions, primarily reflecting the 40% system installation growth over the past year. The tax effects of the non-GAAP items are determined by applying a calculated non-GAAP effective tax rate, which is commonly referred to as the with-and-without method. Field and marketing costs will tick up if the pandemic wanes. In Europe, procedure growth varied by country based on the relative impact of and recovery from the pandemic. The Company defines non-GAAP net income as net income attributable to Intuitive Surgical, Inc., excluding amortization of intangible assets, SBC and long-term incentive plan expenses, litigation charges and recoveries, a gain on the sale of a business, gains (losses) on strategic investments, adjustments attributable to noncontrolling interest in joint venture, net of the related tax effects, and tax adjustments, including the excess tax benefits or deficiencies associated with SBC arrangements and the net tax effects related to intra-entity transfers of non-inventory assets. The Company defines non-GAAP gross profit as gross profit, excluding intangible asset charges and SBC and long-term incentive plan expenses. And so we're going to continue to invest. Investors have assigned a high trading . Even though we've seen growth in the procedures that were specifically targeted by extended use instruments, it's hard to discern what is COVID-related versus what is not. SUNNYVALE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December31, 2021. Full Time Faculty & Clinical Coordinator, Surgical Technologist Program Ask us about our $5,000 Sign on Bonus Rasmussen University Rasmussen University is seeking an experienced Surgical Technologist passionate about taking their own experience and translating that into helping students succeed in meeting their educational and professional goals. To choose your options for e-mail notification, please enter your e-mail address below and click Submit . Starting with procedures. Fourth quarter 2022 instruments and accessories revenue increased by 12% to $941 million, compared with $843 million in the fourth quarter of 2021. With respect to operating expenses, on our last call, we forecast to grow full-year pro forma 2021 operating expenses between 18% and 22% above 2020 levels. I think that's what's been driving our success in the early market. Conversion rates to open surgery were lower in the robotic group compared to the laparoscopic group, 0.6% as compared to 4.9%, and reoperation rates in the 30 days post procedure were comparable between robotic and laparoscopic and lower for robotic as compared to open, 0.6% as compared to 3.1%. The Company uses these non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. The Company ended the fourth quarter of 2022 with $6.74 billion in cash, cash equivalents, and investments, a decrease of $651 million during the quarter, primarily driven by share repurchases of $1 billion and capital expenditures, partially offset by cash generated from operations. So our customers are asking us for advanced instrumentation. Tuesday, October 18, 2022 4:30 PM EDT . Rick Wise -- Stifel Financial Corp. -- Analyst. This presentation contains forward-looking statements. Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results. Yes. Shares of Intuitive Surgical jumped as much as 9.8% on Wednesday to a record high of $891.15 after the robotic surgery company crushed first quarter earnings. . You go from an issue to identification to closure more quickly. Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings and develops, manufactures, and markets the da Vinci Surgical System and the Ion endoluminal system. The authors concluded in part, "When compared to open, the robotic-assisted surgery group is associated with a comparable operative time, shorter length of stay and lower reoperation rate through 30 days. I'll now turn the time over to Marshall to take you through our financial performance in greater detail. Intuitive advances minimally invasive care by innovating at the point of possibility. Can you maybe just talk a little bit about the road map? Non-GAAP income from operations. Statements using words such as estimates, projects, believes, anticipates, plans, expects, intends, may, will, could, should, would, targeted, and similar words and expressions are intended to identify forward-looking statements. For the first three quarters of 2021, it reported $1.4 billion in operating income on $4.2 billion in revenues. How are you thinking about competition? Larry Biegelsen -- Wells Fargo Securities -- Analyst. Now that the dust . Intuitive Surgical, Inc. (NASDAQ:NASDAQ:ISRG) JPMorgan 40th Annual Healthcare Conference January 12, 2022 3:45 PM ETCompany ParticipantsGary Guthart - CEOJamie Samath - CFOBrian King -. During 2020, da Vinci procedure volumes and system placements were significantly impacted by the COVID-19 pandemic, as healthcare systems around the world diverted resources to respond to COVID-19. Some of them are included in our service contracts, some of them are on a per-use basis. Is Intuitive Surgical Stock Still Worth Buying Hand Over Fist in 2023? Management addresses these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP net income attributable to Intuitive Surgical, Inc. and non-GAAP EPS and evaluating non-GAAP net income attributable to Intuitive Surgical, Inc. and non-GAAP EPS together with net income attributable to Intuitive Surgical, Inc. and net income per share attributable to Intuitive Surgical, Inc. calculated in accordance with GAAP. The reason I mentioned it early is I think when we've had pretty strong capital quarters the last few, one of the things we want to look for is, are we building unused capacity into the field that -- where procedures softer that would stall us out. Long-term incentive plan expense relates to phantom share awards granted in China by the Companys Intuitive-Fosun joint venture to its employees that vest over four years and can remain outstanding for seven to ten years. So here's kind of where we stand with the backlog. What we've seen, though, is that what happens in the PowerPoints and what happens a year later is different. Gary S. Guthart Chief Executive Officer, Member of the Board of Directors. Based in Sunnyvale, California. Gary S. Guthart Chief Executive Officer, Member of the Board of Directors.

Quaker Baked Flats Discontinued, Harris County Noise Ordinance Time, Articles I